Protean eGov Technologies Limi
Protean eGov Technologies Limi (PROTEAN.BO) Stock Competitors & Peer Comparison
See (PROTEAN.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PROTEAN.BO | ₹627.40 | -3.11% | 25.6B | 28.38 | ₹22.22 | +1.59% |
| TCS.NS | ₹2,276.20 | -1.77% | 8.4T | 16.97 | ₹136.03 | +6.07% |
| TCS.BO | ₹2,276.70 | -1.75% | 8.3T | 16.95 | ₹136.13 | +6.07% |
| INFY.BO | ₹1,167.45 | -0.59% | 4.7T | 16.76 | ₹69.73 | +3.85% |
| INFY.NS | ₹1,167.70 | -0.58% | 4.7T | 15.14 | ₹77.16 | +3.85% |
| HCLTECH.BO | ₹1,161.70 | -0.18% | 3.2T | 19.01 | ₹61.38 | +5.15% |
| HCLTECH.NS | ₹1,161.90 | -0.18% | 3.2T | 19.00 | ₹61.34 | +5.15% |
| WIPRO.NS | ₹203.73 | +0.31% | 2.2T | 16.48 | ₹12.55 | +5.32% |
| WIPRO.BO | ₹203.85 | +0.37% | 2.2T | 16.45 | ₹12.57 | +5.32% |
| LTIM.NS | ₹4,535.00 | +2.08% | 1.3T | 28.28 | ₹160.34 | +1.65% |
Stock Comparison
PROTEAN.BO vs TCS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TCS.NS has a market cap of 8.4T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TCS.NS trades at ₹2,276.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TCS.NS's P/E ratio is 16.97. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TCS.NS's ROE of +0.46%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TCS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TCS.NS's competition here
PROTEAN.BO vs TCS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TCS.BO has a market cap of 8.3T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TCS.BO trades at ₹2,276.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TCS.BO's P/E ratio is 16.95. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TCS.BO's ROE of +0.46%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TCS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TCS.BO's competition here
PROTEAN.BO vs INFY.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, INFY.BO has a market cap of 4.7T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while INFY.BO trades at ₹1,167.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas INFY.BO's P/E ratio is 16.76. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to INFY.BO's ROE of +0.32%. Regarding short-term risk, PROTEAN.BO is more volatile compared to INFY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check INFY.BO's competition here
PROTEAN.BO vs INFY.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, INFY.NS has a market cap of 4.7T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while INFY.NS trades at ₹1,167.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas INFY.NS's P/E ratio is 15.14. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to INFY.NS's ROE of +0.32%. Regarding short-term risk, PROTEAN.BO is more volatile compared to INFY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check INFY.NS's competition here
PROTEAN.BO vs HCLTECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HCLTECH.BO has a market cap of 3.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HCLTECH.BO trades at ₹1,161.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HCLTECH.BO's P/E ratio is 19.01. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HCLTECH.BO's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HCLTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HCLTECH.BO's competition here
PROTEAN.BO vs HCLTECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HCLTECH.NS has a market cap of 3.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HCLTECH.NS trades at ₹1,161.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HCLTECH.NS's P/E ratio is 19.00. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HCLTECH.NS's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HCLTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HCLTECH.NS's competition here
PROTEAN.BO vs WIPRO.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, WIPRO.NS has a market cap of 2.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while WIPRO.NS trades at ₹203.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas WIPRO.NS's P/E ratio is 16.48. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to WIPRO.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to WIPRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check WIPRO.NS's competition here
PROTEAN.BO vs WIPRO.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, WIPRO.BO has a market cap of 2.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while WIPRO.BO trades at ₹203.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas WIPRO.BO's P/E ratio is 16.45. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to WIPRO.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to WIPRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check WIPRO.BO's competition here
PROTEAN.BO vs LTIM.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, LTIM.NS has a market cap of 1.3T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while LTIM.NS trades at ₹4,535.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas LTIM.NS's P/E ratio is 28.28. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to LTIM.NS's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is less volatile compared to LTIM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTIM.NS's competition here
PROTEAN.BO vs TECHM.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TECHM.NS has a market cap of 1.3T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TECHM.NS trades at ₹1,458.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TECHM.NS's P/E ratio is 26.49. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TECHM.NS's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TECHM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TECHM.NS's competition here
PROTEAN.BO vs TECHM.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TECHM.BO has a market cap of 1.3T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TECHM.BO trades at ₹1,458.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TECHM.BO's P/E ratio is 27.51. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TECHM.BO's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TECHM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TECHM.BO's competition here
PROTEAN.BO vs LTIM.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, LTIM.BO has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while LTIM.BO trades at ₹3,982.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas LTIM.BO's P/E ratio is 25.03. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to LTIM.BO's ROE of +0.21%. Regarding short-term risk, PROTEAN.BO is less volatile compared to LTIM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTIM.BO's competition here
PROTEAN.BO vs LTM.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, LTM.NS has a market cap of 1.2T. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while LTM.NS trades at ₹3,970.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas LTM.NS's P/E ratio is 23.60. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to LTM.NS's ROE of +0.29%. Regarding short-term risk, PROTEAN.BO is less volatile compared to LTM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTM.NS's competition here
PROTEAN.BO vs PERSISTENT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, PERSISTENT.BO has a market cap of 787.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while PERSISTENT.BO trades at ₹5,104.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas PERSISTENT.BO's P/E ratio is 45.50. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to PERSISTENT.BO's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to PERSISTENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check PERSISTENT.BO's competition here
PROTEAN.BO vs PERSISTENT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, PERSISTENT.NS has a market cap of 787.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while PERSISTENT.NS trades at ₹5,105.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas PERSISTENT.NS's P/E ratio is 42.41. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to PERSISTENT.NS's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to PERSISTENT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check PERSISTENT.NS's competition here
PROTEAN.BO vs COFORGE.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, COFORGE.NS has a market cap of 469.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while COFORGE.NS trades at ₹1,422.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas COFORGE.NS's P/E ratio is 31.90. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to COFORGE.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to COFORGE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check COFORGE.NS's competition here
PROTEAN.BO vs COFORGE.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, COFORGE.BO has a market cap of 469.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while COFORGE.BO trades at ₹1,423.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas COFORGE.BO's P/E ratio is 31.94. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to COFORGE.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to COFORGE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check COFORGE.BO's competition here
PROTEAN.BO vs MPHASIS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MPHASIS.BO has a market cap of 428.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MPHASIS.BO trades at ₹2,264.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MPHASIS.BO's P/E ratio is 23.79. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MPHASIS.BO's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MPHASIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MPHASIS.BO's competition here
PROTEAN.BO vs MPHASIS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MPHASIS.NS has a market cap of 428.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MPHASIS.NS trades at ₹2,265.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MPHASIS.NS's P/E ratio is 23.81. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MPHASIS.NS's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MPHASIS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MPHASIS.NS's competition here
PROTEAN.BO vs LTTS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, LTTS.BO has a market cap of 376B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while LTTS.BO trades at ₹3,538.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas LTTS.BO's P/E ratio is 30.65. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to LTTS.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to LTTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTTS.BO's competition here
PROTEAN.BO vs LTTS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, LTTS.NS has a market cap of 375.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while LTTS.NS trades at ₹3,540.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas LTTS.NS's P/E ratio is 30.68. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to LTTS.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is more volatile compared to LTTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check LTTS.NS's competition here
PROTEAN.BO vs HEXT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HEXT.NS has a market cap of 308.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HEXT.NS trades at ₹507.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HEXT.NS's P/E ratio is 22.43. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HEXT.NS's ROE of +0.23%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HEXT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HEXT.NS's competition here
PROTEAN.BO vs TATATECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TATATECH.NS has a market cap of 275B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TATATECH.NS trades at ₹706.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TATATECH.NS's P/E ratio is 50.21. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TATATECH.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TATATECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TATATECH.NS's competition here
PROTEAN.BO vs TATATECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TATATECH.BO has a market cap of 274.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TATATECH.BO trades at ₹705.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TATATECH.BO's P/E ratio is 50.26. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TATATECH.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TATATECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TATATECH.BO's competition here
PROTEAN.BO vs KPITTECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, KPITTECH.NS has a market cap of 206B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while KPITTECH.NS trades at ₹784.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas KPITTECH.NS's P/E ratio is 32.50. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to KPITTECH.NS's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to KPITTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check KPITTECH.NS's competition here
PROTEAN.BO vs KPITTECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, KPITTECH.BO has a market cap of 205.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while KPITTECH.BO trades at ₹786.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas KPITTECH.BO's P/E ratio is 32.43. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to KPITTECH.BO's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to KPITTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check KPITTECH.BO's competition here
PROTEAN.BO vs FSL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, FSL.BO has a market cap of 193.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while FSL.BO trades at ₹278.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas FSL.BO's P/E ratio is 29.37. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to FSL.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to FSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check FSL.BO's competition here
PROTEAN.BO vs FSL.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, FSL.NS has a market cap of 193.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while FSL.NS trades at ₹277.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas FSL.NS's P/E ratio is 29.32. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to FSL.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to FSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check FSL.NS's competition here
PROTEAN.BO vs REDINGTON.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, REDINGTON.NS has a market cap of 175.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while REDINGTON.NS trades at ₹224.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas REDINGTON.NS's P/E ratio is 11.77. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to REDINGTON.NS's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to REDINGTON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check REDINGTON.NS's competition here
PROTEAN.BO vs REDINGTON.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, REDINGTON.BO has a market cap of 175.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while REDINGTON.BO trades at ₹224.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas REDINGTON.BO's P/E ratio is 11.76. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to REDINGTON.BO's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is less volatile compared to REDINGTON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check REDINGTON.BO's competition here
PROTEAN.BO vs ECLERX.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ECLERX.BO has a market cap of 149.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ECLERX.BO trades at ₹1,567.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ECLERX.BO's P/E ratio is 21.31. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ECLERX.BO's ROE of +0.29%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ECLERX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ECLERX.BO's competition here
PROTEAN.BO vs ECLERX.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ECLERX.NS has a market cap of 148B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ECLERX.NS trades at ₹1,567.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ECLERX.NS's P/E ratio is 21.33. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ECLERX.NS's ROE of +0.29%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ECLERX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ECLERX.NS's competition here
PROTEAN.BO vs HEXAWARE.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HEXAWARE.NS trades at ₹470.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HEXAWARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HEXAWARE.NS's competition here
PROTEAN.BO vs ZENSARTECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ZENSARTECH.BO has a market cap of 112.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ZENSARTECH.BO trades at ₹488.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ZENSARTECH.BO's P/E ratio is 15.31. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ZENSARTECH.BO's ROE of +0.18%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ZENSARTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ZENSARTECH.BO's competition here
PROTEAN.BO vs ZENSARTECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ZENSARTECH.NS has a market cap of 111.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ZENSARTECH.NS trades at ₹487.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ZENSARTECH.NS's P/E ratio is 14.64. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ZENSARTECH.NS's ROE of +0.18%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ZENSARTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ZENSARTECH.NS's competition here
PROTEAN.BO vs BSOFT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, BSOFT.BO has a market cap of 92.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while BSOFT.BO trades at ₹324.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas BSOFT.BO's P/E ratio is 17.88. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to BSOFT.BO's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to BSOFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check BSOFT.BO's competition here
PROTEAN.BO vs BSOFT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, BSOFT.NS has a market cap of 92.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while BSOFT.NS trades at ₹324.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas BSOFT.NS's P/E ratio is 17.87. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to BSOFT.NS's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to BSOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check BSOFT.NS's competition here
PROTEAN.BO vs SONATSOFTW.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SONATSOFTW.NS has a market cap of 75.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SONATSOFTW.NS trades at ₹270.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SONATSOFTW.NS's P/E ratio is 16.37. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SONATSOFTW.NS's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SONATSOFTW.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SONATSOFTW.NS's competition here
PROTEAN.BO vs SONATSOFTW.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SONATSOFTW.BO has a market cap of 75.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SONATSOFTW.BO trades at ₹270.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SONATSOFTW.BO's P/E ratio is 16.35. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SONATSOFTW.BO's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SONATSOFTW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SONATSOFTW.BO's competition here
PROTEAN.BO vs RSYSTEMINT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, RSYSTEMINT.BO has a market cap of 63.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while RSYSTEMINT.BO trades at ₹531.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas RSYSTEMINT.BO's P/E ratio is 106.05. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to RSYSTEMINT.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RSYSTEMINT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMINT.BO's competition here
PROTEAN.BO vs HAPPSTMNDS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HAPPSTMNDS.NS has a market cap of 56.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HAPPSTMNDS.NS trades at ₹376.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HAPPSTMNDS.NS's P/E ratio is 30.35. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HAPPSTMNDS.NS's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HAPPSTMNDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HAPPSTMNDS.NS's competition here
PROTEAN.BO vs HAPPSTMNDS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, HAPPSTMNDS.BO has a market cap of 56B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while HAPPSTMNDS.BO trades at ₹376.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas HAPPSTMNDS.BO's P/E ratio is 30.30. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to HAPPSTMNDS.BO's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is more volatile compared to HAPPSTMNDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check HAPPSTMNDS.BO's competition here
PROTEAN.BO vs MASTEK.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MASTEK.BO has a market cap of 51.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MASTEK.BO trades at ₹1,631.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MASTEK.BO's P/E ratio is 12.90. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MASTEK.BO's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MASTEK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MASTEK.BO's competition here
PROTEAN.BO vs MASTEK.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MASTEK.NS has a market cap of 51.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MASTEK.NS trades at ₹1,632.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MASTEK.NS's P/E ratio is 12.89. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MASTEK.NS's ROE of +0.15%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MASTEK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MASTEK.NS's competition here
PROTEAN.BO vs DATAMATICS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DATAMATICS.NS has a market cap of 46.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DATAMATICS.NS trades at ₹766.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DATAMATICS.NS's P/E ratio is 23.65. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DATAMATICS.NS's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DATAMATICS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DATAMATICS.NS's competition here
PROTEAN.BO vs DATAMATICS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DATAMATICS.BO has a market cap of 45.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DATAMATICS.BO trades at ₹767.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DATAMATICS.BO's P/E ratio is 23.42. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DATAMATICS.BO's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DATAMATICS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DATAMATICS.BO's competition here
PROTEAN.BO vs ASMTEC.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ASMTEC.BO has a market cap of 38.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ASMTEC.BO trades at ₹3,198.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ASMTEC.BO's P/E ratio is 78.88. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ASMTEC.BO's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ASMTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ASMTEC.BO's competition here
PROTEAN.BO vs CAMS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CAMS.NS has a market cap of 38.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CAMS.NS trades at ₹773.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CAMS.NS's P/E ratio is 40.17. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CAMS.NS's ROE of +0.40%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CAMS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CAMS.NS's competition here
PROTEAN.BO vs CAMS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CAMS.BO has a market cap of 38.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CAMS.BO trades at ₹772.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CAMS.BO's P/E ratio is 40.21. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CAMS.BO's ROE of +0.40%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CAMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CAMS.BO's competition here
PROTEAN.BO vs CIGNITITEC.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CIGNITITEC.BO has a market cap of 34.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CIGNITITEC.BO trades at ₹1,265.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CIGNITITEC.BO's P/E ratio is 11.58. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CIGNITITEC.BO's ROE of +0.31%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CIGNITITEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CIGNITITEC.BO's competition here
PROTEAN.BO vs CIGNITITEC.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CIGNITITEC.NS has a market cap of 34.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CIGNITITEC.NS trades at ₹1,260.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CIGNITITEC.NS's P/E ratio is 11.53. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CIGNITITEC.NS's ROE of +0.31%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CIGNITITEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CIGNITITEC.NS's competition here
PROTEAN.BO vs RSYSTEMS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, RSYSTEMS.NS has a market cap of 31.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while RSYSTEMS.NS trades at ₹265.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas RSYSTEMS.NS's P/E ratio is 15.56. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to RSYSTEMS.NS's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RSYSTEMS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMS.NS's competition here
PROTEAN.BO vs RSYSTEMS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, RSYSTEMS.BO has a market cap of 31.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while RSYSTEMS.BO trades at ₹265.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas RSYSTEMS.BO's P/E ratio is 17.89. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to RSYSTEMS.BO's ROE of +0.26%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RSYSTEMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RSYSTEMS.BO's competition here
PROTEAN.BO vs RPSGVENT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, RPSGVENT.NS has a market cap of 30.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while RPSGVENT.NS trades at ₹932.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas RPSGVENT.NS's P/E ratio is -33.00. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to RPSGVENT.NS's ROE of -0.03%. Regarding short-term risk, PROTEAN.BO is less volatile compared to RPSGVENT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check RPSGVENT.NS's competition here
PROTEAN.BO vs RPSGVENT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, RPSGVENT.BO has a market cap of 30.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while RPSGVENT.BO trades at ₹933.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas RPSGVENT.BO's P/E ratio is -33.00. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to RPSGVENT.BO's ROE of -0.03%. Regarding short-term risk, PROTEAN.BO is more volatile compared to RPSGVENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check RPSGVENT.BO's competition here
PROTEAN.BO vs SASKEN.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SASKEN.BO has a market cap of 29.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SASKEN.BO trades at ₹2,004.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SASKEN.BO's P/E ratio is 54.56. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SASKEN.BO's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SASKEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SASKEN.BO's competition here
PROTEAN.BO vs SASKEN.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SASKEN.NS has a market cap of 29.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SASKEN.NS trades at ₹2,006.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SASKEN.NS's P/E ratio is 54.41. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SASKEN.NS's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SASKEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SASKEN.NS's competition here
PROTEAN.BO vs PROTEAN.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, PROTEAN.NS has a market cap of 25.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while PROTEAN.NS trades at ₹627.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas PROTEAN.NS's P/E ratio is 28.41. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to PROTEAN.NS's ROE of +0.10%. Regarding short-term risk, PROTEAN.BO is more volatile compared to PROTEAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check PROTEAN.NS's competition here
PROTEAN.BO vs DSSL.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DSSL.NS has a market cap of 24.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DSSL.NS trades at ₹1,731.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DSSL.NS's P/E ratio is 28.68. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DSSL.NS's ROE of +0.36%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DSSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DSSL.NS's competition here
PROTEAN.BO vs DSSL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DSSL.BO has a market cap of 24.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DSSL.BO trades at ₹1,729.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DSSL.BO's P/E ratio is 28.63. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DSSL.BO's ROE of +0.36%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DSSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DSSL.BO's competition here
PROTEAN.BO vs SAKSOFT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SAKSOFT.NS has a market cap of 18.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SAKSOFT.NS trades at ₹146.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SAKSOFT.NS's P/E ratio is 15.26. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SAKSOFT.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SAKSOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SAKSOFT.NS's competition here
PROTEAN.BO vs SAKSOFT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SAKSOFT.BO has a market cap of 18.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SAKSOFT.BO trades at ₹146.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SAKSOFT.BO's P/E ratio is 15.24. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SAKSOFT.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SAKSOFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SAKSOFT.BO's competition here
PROTEAN.BO vs ACCELYA.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ACCELYA.NS has a market cap of 17.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ACCELYA.NS trades at ₹1,131.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ACCELYA.NS's P/E ratio is 15.83. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ACCELYA.NS's ROE of +0.35%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ACCELYA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ACCELYA.NS's competition here
PROTEAN.BO vs ACCELYA.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ACCELYA.BO has a market cap of 17B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ACCELYA.BO trades at ₹1,129.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ACCELYA.BO's P/E ratio is 15.79. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ACCELYA.BO's ROE of +0.35%. Regarding short-term risk, PROTEAN.BO is more volatile compared to ACCELYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check ACCELYA.BO's competition here
PROTEAN.BO vs MCLOUD.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MCLOUD.NS has a market cap of 15.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MCLOUD.NS trades at ₹27.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MCLOUD.NS's P/E ratio is 14.82. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MCLOUD.NS's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MCLOUD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MCLOUD.NS's competition here
PROTEAN.BO vs MCLOUD.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MCLOUD.BO has a market cap of 15.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MCLOUD.BO trades at ₹27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MCLOUD.BO's P/E ratio is 14.81. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MCLOUD.BO's ROE of +0.20%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MCLOUD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MCLOUD.BO's competition here
PROTEAN.BO vs MMWL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MMWL.BO has a market cap of 15.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MMWL.BO trades at ₹13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MMWL.BO's P/E ratio is 275.00. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MMWL.BO's ROE of +0.05%. Regarding short-term risk, PROTEAN.BO is more volatile compared to MMWL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check MMWL.BO's competition here
PROTEAN.BO vs EXPLEOSOL.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, EXPLEOSOL.NS has a market cap of 14B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while EXPLEOSOL.NS trades at ₹898.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas EXPLEOSOL.NS's P/E ratio is 11.33. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to EXPLEOSOL.NS's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to EXPLEOSOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check EXPLEOSOL.NS's competition here
PROTEAN.BO vs EXPLEOSOL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, EXPLEOSOL.BO has a market cap of 14B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while EXPLEOSOL.BO trades at ₹899.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas EXPLEOSOL.BO's P/E ratio is 11.29. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to EXPLEOSOL.BO's ROE of +0.17%. Regarding short-term risk, PROTEAN.BO is less volatile compared to EXPLEOSOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check EXPLEOSOL.BO's competition here
PROTEAN.BO vs AURUM.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, AURUM.BO has a market cap of 13.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while AURUM.BO trades at ₹180.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas AURUM.BO's P/E ratio is 661.85. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to AURUM.BO's ROE of +0.00%. Regarding short-term risk, PROTEAN.BO is less volatile compared to AURUM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check AURUM.BO's competition here
PROTEAN.BO vs AURUM.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, AURUM.NS has a market cap of 13.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while AURUM.NS trades at ₹180.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas AURUM.NS's P/E ratio is 713.24. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to AURUM.NS's ROE of +0.00%. Regarding short-term risk, PROTEAN.BO is less volatile compared to AURUM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check AURUM.NS's competition here
PROTEAN.BO vs ORIENTTECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ORIENTTECH.NS has a market cap of 12.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ORIENTTECH.NS trades at ₹286.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ORIENTTECH.NS's P/E ratio is 59.73. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ORIENTTECH.NS's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ORIENTTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ORIENTTECH.NS's competition here
PROTEAN.BO vs NINSYS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, NINSYS.NS has a market cap of 12.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while NINSYS.NS trades at ₹671.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas NINSYS.NS's P/E ratio is 39.73. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to NINSYS.NS's ROE of +0.44%. Regarding short-term risk, PROTEAN.BO is less volatile compared to NINSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check NINSYS.NS's competition here
PROTEAN.BO vs NINSYS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, NINSYS.BO has a market cap of 12B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while NINSYS.BO trades at ₹671.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas NINSYS.BO's P/E ratio is 39.40. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to NINSYS.BO's ROE of +0.49%. Regarding short-term risk, PROTEAN.BO is less volatile compared to NINSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check NINSYS.BO's competition here
PROTEAN.BO vs BGDL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, BGDL.BO has a market cap of 11.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while BGDL.BO trades at ₹113.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas BGDL.BO's P/E ratio is 406.43. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to BGDL.BO's ROE of +0.07%. Regarding short-term risk, PROTEAN.BO is less volatile compared to BGDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check BGDL.BO's competition here
PROTEAN.BO vs 3IINFOTECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, 3IINFOTECH.BO has a market cap of 9.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while 3IINFOTECH.BO trades at ₹54.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas 3IINFOTECH.BO's P/E ratio is 111.67. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to 3IINFOTECH.BO's ROE of +0.00%. Regarding short-term risk, PROTEAN.BO is less volatile compared to 3IINFOTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check 3IINFOTECH.BO's competition here
PROTEAN.BO vs XCHANGING.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, XCHANGING.BO has a market cap of 7.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while XCHANGING.BO trades at ₹66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas XCHANGING.BO's P/E ratio is 12.90. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to XCHANGING.BO's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is more volatile compared to XCHANGING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check XCHANGING.BO's competition here
PROTEAN.BO vs XCHANGING.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, XCHANGING.NS has a market cap of 7.4B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while XCHANGING.NS trades at ₹66.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas XCHANGING.NS's P/E ratio is 12.86. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to XCHANGING.NS's ROE of +0.16%. Regarding short-term risk, PROTEAN.BO is more volatile compared to XCHANGING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PROTEAN.BO.Check XCHANGING.NS's competition here
PROTEAN.BO vs VAKRANGEE.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, VAKRANGEE.BO has a market cap of 7.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while VAKRANGEE.BO trades at ₹6.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas VAKRANGEE.BO's P/E ratio is 66.40. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to VAKRANGEE.BO's ROE of +0.05%. Regarding short-term risk, PROTEAN.BO is less volatile compared to VAKRANGEE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check VAKRANGEE.BO's competition here
PROTEAN.BO vs VAKRANGEE.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, VAKRANGEE.NS has a market cap of 7.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while VAKRANGEE.NS trades at ₹6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas VAKRANGEE.NS's P/E ratio is 66.30. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to VAKRANGEE.NS's ROE of +0.05%. Regarding short-term risk, PROTEAN.BO is less volatile compared to VAKRANGEE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check VAKRANGEE.NS's competition here
PROTEAN.BO vs ADSL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ADSL.BO has a market cap of 7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ADSL.BO trades at ₹122.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ADSL.BO's P/E ratio is 21.82. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ADSL.BO's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ADSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ADSL.BO's competition here
PROTEAN.BO vs ADSL.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ADSL.NS has a market cap of 7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ADSL.NS trades at ₹122.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ADSL.NS's P/E ratio is 21.78. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ADSL.NS's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ADSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ADSL.NS's competition here
PROTEAN.BO vs MINDTECK.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MINDTECK.BO has a market cap of 6.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MINDTECK.BO trades at ₹203.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MINDTECK.BO's P/E ratio is 23.30. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MINDTECK.BO's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MINDTECK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MINDTECK.BO's competition here
PROTEAN.BO vs MINDTECK.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, MINDTECK.NS has a market cap of 6.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while MINDTECK.NS trades at ₹203.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas MINDTECK.NS's P/E ratio is 23.26. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to MINDTECK.NS's ROE of +0.11%. Regarding short-term risk, PROTEAN.BO is less volatile compared to MINDTECK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check MINDTECK.NS's competition here
PROTEAN.BO vs ONWARDTEC.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ONWARDTEC.NS has a market cap of 6.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ONWARDTEC.NS trades at ₹271.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ONWARDTEC.NS's P/E ratio is 13.83. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ONWARDTEC.NS's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ONWARDTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ONWARDTEC.NS's competition here
PROTEAN.BO vs ONWARDTEC.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, ONWARDTEC.BO has a market cap of 6.1B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while ONWARDTEC.BO trades at ₹272.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas ONWARDTEC.BO's P/E ratio is 13.80. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to ONWARDTEC.BO's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to ONWARDTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check ONWARDTEC.BO's competition here
PROTEAN.BO vs INSPIRISYS.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, INSPIRISYS.BO has a market cap of 4.8B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while INSPIRISYS.BO trades at ₹126.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas INSPIRISYS.BO's P/E ratio is 12.22. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to INSPIRISYS.BO's ROE of +0.57%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INSPIRISYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INSPIRISYS.BO's competition here
PROTEAN.BO vs INSPIRISYS.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, INSPIRISYS.NS has a market cap of 4.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while INSPIRISYS.NS trades at ₹125.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas INSPIRISYS.NS's P/E ratio is 12.16. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to INSPIRISYS.NS's ROE of +0.57%. Regarding short-term risk, PROTEAN.BO is less volatile compared to INSPIRISYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check INSPIRISYS.NS's competition here
PROTEAN.BO vs CYBERTECH.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CYBERTECH.NS has a market cap of 4.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CYBERTECH.NS trades at ₹147.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CYBERTECH.NS's P/E ratio is 15.16. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CYBERTECH.NS's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CYBERTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CYBERTECH.NS's competition here
PROTEAN.BO vs CYBERTECH.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, CYBERTECH.BO has a market cap of 4.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while CYBERTECH.BO trades at ₹147.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas CYBERTECH.BO's P/E ratio is 15.16. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to CYBERTECH.BO's ROE of +0.14%. Regarding short-term risk, PROTEAN.BO is less volatile compared to CYBERTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check CYBERTECH.BO's competition here
PROTEAN.BO vs DIGISPICE.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DIGISPICE.BO has a market cap of 4.6B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DIGISPICE.BO trades at ₹19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DIGISPICE.BO's P/E ratio is 20.90. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DIGISPICE.BO's ROE of +0.09%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DIGISPICE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DIGISPICE.BO's competition here
PROTEAN.BO vs DIGISPICE.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, DIGISPICE.NS has a market cap of 4.5B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while DIGISPICE.NS trades at ₹19.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas DIGISPICE.NS's P/E ratio is 20.78. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to DIGISPICE.NS's ROE of +0.09%. Regarding short-term risk, PROTEAN.BO is less volatile compared to DIGISPICE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check DIGISPICE.NS's competition here
PROTEAN.BO vs XTGLOBAL.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, XTGLOBAL.BO has a market cap of 4.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while XTGLOBAL.BO trades at ₹31.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas XTGLOBAL.BO's P/E ratio is 49.05. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to XTGLOBAL.BO's ROE of +0.06%. Regarding short-term risk, PROTEAN.BO is less volatile compared to XTGLOBAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check XTGLOBAL.BO's competition here
PROTEAN.BO vs TERASOFT.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TERASOFT.NS has a market cap of 4.3B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TERASOFT.NS trades at ₹357.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TERASOFT.NS's P/E ratio is 20.43. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TERASOFT.NS's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TERASOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TERASOFT.NS's competition here
PROTEAN.BO vs TERASOFT.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, TERASOFT.BO has a market cap of 4.2B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while TERASOFT.BO trades at ₹356.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas TERASOFT.BO's P/E ratio is 20.35. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to TERASOFT.BO's ROE of +0.19%. Regarding short-term risk, PROTEAN.BO is less volatile compared to TERASOFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check TERASOFT.BO's competition here
PROTEAN.BO vs SIGMA.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SIGMA.NS has a market cap of 3.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SIGMA.NS trades at ₹39.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SIGMA.NS's P/E ratio is 15.54. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SIGMA.NS's ROE of +0.40%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SIGMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SIGMA.NS's competition here
PROTEAN.BO vs SIGMA.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SIGMA.BO has a market cap of 3.9B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SIGMA.BO trades at ₹39.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SIGMA.BO's P/E ratio is 15.48. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SIGMA.BO's ROE of +0.40%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SIGMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SIGMA.BO's competition here
PROTEAN.BO vs SILVERTUC.BO Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SILVERTUC.BO has a market cap of 3.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SILVERTUC.BO trades at ₹153.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SILVERTUC.BO's P/E ratio is 51.83. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SILVERTUC.BO's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SILVERTUC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SILVERTUC.BO's competition here
PROTEAN.BO vs SILVERTUC.NS Comparison May 2026
PROTEAN.BO plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PROTEAN.BO stands at 25.6B. In comparison, SILVERTUC.NS has a market cap of 3.7B. Regarding current trading prices, PROTEAN.BO is priced at ₹627.40, while SILVERTUC.NS trades at ₹152.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PROTEAN.BO currently has a P/E ratio of 28.38, whereas SILVERTUC.NS's P/E ratio is 51.67. In terms of profitability, PROTEAN.BO's ROE is +0.10%, compared to SILVERTUC.NS's ROE of +0.25%. Regarding short-term risk, PROTEAN.BO is less volatile compared to SILVERTUC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PROTEAN.BO.Check SILVERTUC.NS's competition here